These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [A new method of studying synalbumin insulin antagonist]. Kammerer L; Bretán M; Steingaszner O Orv Hetil; 1970 Jun; 111(25):1454-5. PubMed ID: 5454030 [No Abstract] [Full Text] [Related]
27. Effects of the synalbumin insulin antagonist in vivo; its examination with a new method. Kammerer L; Bretán M; Steingaszner O Diabetologia; 1970 Oct; 6(5):473-4. PubMed ID: 5474812 [No Abstract] [Full Text] [Related]
30. The properties of trichloracetic acid-ethanol extracts of human plasma. 2. Physical, chemical and immunological properties of the extracts. Cameron JS; Boyns DR; Jarrett RJ; Keen H Diabetologia; 1966 Sep; 2(2):91-5. PubMed ID: 6005202 [No Abstract] [Full Text] [Related]
34. [New type of microheterogeneity of blood serum albumin]. Troitskiĭ GV; Bagdasar'ian SN Biull Eksp Biol Med; 1973 Aug; 76(8):48-50. PubMed ID: 4777683 [No Abstract] [Full Text] [Related]
35. Isolation of albumin from human serum by means of trichloroacetic acid and ethanol. A comparison of methods. Iwata T; Iwata H; Holland JF Clin Chem; 1968 Jan; 14(1):22-30. PubMed ID: 4965230 [No Abstract] [Full Text] [Related]
36. STUDIES OF THE INSULIN-INHIBITORY EFFECT OF HUMAN ALBUMIN FRACTIONS. ALP H; RECANT L J Clin Invest; 1965 May; 44(5):870-82. PubMed ID: 14276144 [No Abstract] [Full Text] [Related]
37. Synalbumin insulin antagonism in idiopathic hypoglycemia of infancy. Sherman L; Rosenbloom AL Diabetes; 1968 Sep; 17(9):557-9. PubMed ID: 5675315 [No Abstract] [Full Text] [Related]